Advanced search
Publication Cover
Cancer Management and Research Volume 15, 2023 - Issue
Submit an article Journal homepage
406
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab

Paolo Lopedote1 Department of Medicine, St Elizabeth’s Medical Center, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0002-7764-4336View further author information
ORCID Icon &
Mazyar Shadman2 Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA;3 Department of Medicine, University of Washington, Seattle, WA, USACorrespondence[email protected]
View further author information
Pages 257-264 | Received 08 Jan 2023, Accepted 10 Mar 2023, Published online: 14 Mar 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.